AzTrials
AzTrials

Sleep Initiation and Maintenance DisordersAI-RCTNCT02594670

Acupuncture for Insomnia: a Randomized Controlled Trial

A study testing DU20 and HT7 combination, DU20 and SP6 combination and DU20 and SA combination in people with Sleep Initiation and Maintenance Disorders, run by The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine at 3 sites in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Selecting different acupoints as an combination of acupoints is a key factor to clinical efficacy of acupuncture. Different combinations of acupoints will generate different clinical efficacy. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
DU20 and HT7 combination, DU20 and SP6 combination and DU20 and SA combination
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
333 participants
Where
3 sitesChina
Study dates
Oct 2015to Aug 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosed as insomnia based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition,2013, American psychiatric association
  • PSQI score >7
  • AIS score ≥6
  • SDS ≤60
  • SAS ≤60
  • Age between 18 and 65 years old
  • Not involved in other clinical trial in the lasted 6 months before screening
  • Have the ability to write the informed consent.

Who cannot join

  • Breathing-related sleep disorders
  • Circadian rhythm sleep-wake disorders
  • Medication-induced sleep disorder
  • Substance induced sleep disorders,such as alcohol, coffee, strong tea
  • Secondary insomnia caused by systemic diseases or caused by external environment disturbance
  • Pregnant or lactating women
Show all 11Show fewer
  • Combined with serious cardiovascular, lung, liver, kidney, hematopoietic system, and mental diseases
  • Advanced malignant tumor or other serious debilitating diseases
  • Location of acupoints combined with infection and bleeding
  • Declined to acupuncture
  • Couldn't provide the written informed consent.

Trial locations and contacts

3 sites in 1 country.

Yan Wang contact

48770045@qq.com

China3 sites
  • Second Hospital of Hunan University of Chinese Medicine

    Changsha, Hunan, 410005

  • First Hospital of Hunan University of Chinese Medicine

    Changsha, Hunan, 410007

  • Hengyang hospital of Hunan University of Chinese Medicine

    Hengyang, Hunan

    Zenghui Yue, 624755064@qq.com

Other trials in China

About this study

Official title: Acupuncture Based on Different Acupoints Combination for Insomnia: a Randomized Controlled Trial

Selecting different acupoints as an combination of acupoints is a key factor to clinical efficacy of acupuncture. Different combinations of acupoints will generate different clinical efficacy. So,the purpose of this study is to determine the different clinical efficacy among three types of combinations of acupoints in the treatment of primary insomnia.

Being tested
DU20 and HT7 combination, DU20 and SP6 combination, DU20 and SA combination
Keywords
acupoints, insomnia, acupuncture, randomized controlled trial
Medical subject headings
Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DU20 and HT7 combinationOther

    acupoints combination includes Baihui (DU20) and Shenmen(HT7),which was considered as the optimal clinical efficay among various combinations of acupoints.

  • DU20 and SP6 combinationOther

    acupoints combination of Baihui (DU20) and Sanyinjiao (SP6), which should have some clinical efficay among various combinations of acupoints.

  • DU20 and SA combinationOther

    Combination of Baihui (DU20) and a Sham acupoint (SA), which should have least clinical efficacy among these three types of acupoints combinations.

Study groups in NCT02594670
Study groupRoleWhat they receive
DU20 and HT7 combinationExperimentalcombination of two acupoints based on location and Heart meridian, including Baihui (DU20) and Shenmen(HT7).
Receives: Other: DU20 and HT7 combination
DU20 and SP6 combinationOthercombination of two acupoints based on location and Spleen meridian, including Baihui (DU20) and Sanyinjiao(SP6).
Receives: Other: DU20 and SP6 combination
DU20 and SA combinationSham comparatorcombination of local acupoint Baihui (DU20) and a sham acupoint (SA) not belonging to any regular meridian or acupoint.
Receives: Other: DU20 and SA combination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pittsburgh sleep quality index (PSQI)

    Measured: 4 weeks

Secondary outcomes (4)
  1. Athens Insomnia Scale (AIS)

    Measured: 4 weeks and 8 weeks

  2. Short Form 36-item Health Survey(SF-36)

    Measured: 4 weeks and 8 weeks

  3. Self-anxiety scale (SAS)

    Measured: 4 weeks and 8 weeks

  4. Self-depression scale (SDS)

    Measured: 4 weeks and 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Nov 2015 (estimated)
  2. Study startOct 2015
  3. Primary completionDec 2016 (estimated)
  4. Study completionAug 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
333 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02594670
Sponsor's protocol ID
2014CB543102-1
Acronym
AI-RCT
Status last verified
Mar 2015
First submitted
30 Sep 2014
Last updated
3 Nov 2015
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing DU20 and HT7 combination, DU20 and SP6 combination and DU20 and SA combination in people with Sleep Initiation and Maintenance Disorders, run by The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine at 3 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Nov 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yan Wang (48770045@qq.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pittsburgh sleep quality index (PSQI) (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in